• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Outcomes of aortic valve-sparing root replacement with cusp repair in connective tissue disease
CONCLUSION: Remodelling and aortic valve repair showed excellent durability at 5 years, even in connective tissue disorders.PMID:37640626 | DOI:10.1016/j.acvd.2023.07.005
Source: Archives of Cardiovascular Diseases - August 28, 2023 Category: Cardiology Authors: Pichoy Danial Pierre Demondion Mathieu Debauchez Pascal Leprince Emmanuel Lansac Source Type: research

Minimally invasive, surgical, and transcatheter aortic valve replacement: Network meta-analysis
CONCLUSIONS: MS was protective against 30-day mortality, stroke, AKI, and long-term mortality compared to FS; TAVR showed higher rates of 30-day PVL and PPM but was protective against AKI. Conversely, MT showed higher rates of 30-day PVL and major bleeding. With the emergence of TAVR, the appropriate benchmarks for SAVR comparison in future trials should be the minimally-invasive SAVR approaches to provide clinical equipoise.PMID:37611742 | DOI:10.1016/j.jjcc.2023.08.010
Source: Journal of Cardiology - August 23, 2023 Category: Cardiology Authors: Ahmed K Awad Adham Ahmed Dave M Mathew Kathryn S Varghese Serena M Mathew Sofia Khaja Paige C Newell Alexis K Okoh Sameer Hirji Source Type: research

Antithrombotic Medication and Major Complications After Mechanical Aortic Valve Replacement
Patients with mechanical aortic valve replacement (AVR) require lifelong vitamin K antagonist (VKA) therapy for stroke and systemic embolism prevention. However, VKA treatment predisposes patients to various types of bleeding. In the present study, we sought to assess the success of antithrombotic therapy and the occurrence and timing of strokes and bleeding events after mechanical AVR. A total of 308 patients who underwent isolated mechanical AVR were included in the study, and follow-up data were completed for 306 patients (99.4%).
Source: The American Journal of Cardiology - August 5, 2023 Category: Cardiology Authors: Rikhard Bj örn, Joonas Lehto, Markus Malmberg, Vesa Anttila, K.E. Juhani Airaksinen, Jarmo Gunn, Tuomas Kiviniemi Source Type: research

Benchmarking Outcomes of Surgical Aortic Valve Replacement in Patients with Bicuspid Aortic Valves
CONCLUSIONS: In this nationally-representative study, 30-day mortality was similar but risk-adjusted 5-year mortality was significantly lower in bicuspid patients undergoing isolated SAVR compared to tricuspid patients, specifically low-risk and normal left ventricular ejection fraction patients. This analyses provides a much-needed 5-year longitudinal national-level benchmark to better inform the discussion of transcatheter vs SAVR in bicuspid patients.PMID:37454786 | DOI:10.1016/j.athoracsur.2023.06.026
Source: The Annals of Thoracic Surgery - July 16, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Sameer A Hirji Zachary Wegermann Sreekanth Vemulapalli Paige Newell Maria Grau-Sepulveda Sean O'Brien Vinod H Thourani Vinay Badhwar Tsuyoshi Kaneko Source Type: research

Midterm outcomes of minimally invasive mitral valve surgery in a heterogeneous valve pathology cohort: respect or resect?
CONCLUSIONS: Despite a heterogeneous cohort with mixed valve pathologies, there is a high reconstruction rate, low short- and midterm morbidity, mortality and need for re-intervention with comparable outcomes of the resect and respect technique in a specialized MIV center.PMID:37426140 | PMC:PMC10323544 | DOI:10.21037/jtd-22-1796
Source: Journal of Thoracic Disease - July 10, 2023 Category: Respiratory Medicine Authors: Laina Passos Thierry Aymard Patric Biaggi Mohammed Morjan Maximilian Y Emmert Juerg Gruenenfelder Diana Reser Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20